Foot health and quality of life in women with breast cancer undergoing chemotherapy: a cross-sectional study.

Background: Chemotherapy is one of the most widely used therapies for breast cancer, triggering important repercussions on people's quality of life. However, little research has been undertaken about podiatric adverse effects. This study aimed was to determine the prevalence of podiatric pathology developed in people with breast cancer who receive chemotherapy.

Wellbeing and Complementary Therapies in Breast Cancer Peripheral Neuropathy Care: A Scoping Review Focused on Foot Health.

Background: Chemotherapy-induced peripheral neuropathy is a multidimensional health problem. Up to now, little evidence has been found concerning its impact on quality of life and foot health. Evaluation tools and prevention and treatment strategies must be reported.

[Single prostatic metastasis of a small cell lung carcinoma].

Background: To make the difference between two uncommon entities, small cell prostate carcinoma and prostatic metastasis of small cell lung cancer.

Methods: We describe a case of single extrapulmonar metastasis in the prostate from small lung carcinoma.

Results: We describe a case of single extrapulmonar metastasis in the prostate from small lung carcinoma.

Role of pegylated liposomal doxorubicin (Caelyx) in the treatment of relapsing ovarian cancer.

The most significant factor predicting response to second-line chemotherapy is the time interval elapsed from the end of chemotherapy to relapse occurrence. Two types of situations may be considered: patients with platinum-sensitive relapse (relapse-free interval longer than 6 months) and patients with platinum-refractory relapse (progression during treatment or relapse-free interval under 6 months). Pegylated liposomal doxorubicin is a doxorubicin formulation.